360 related articles for article (PubMed ID: 32822542)
21. Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI.
Zhou J; Lu J; Gao C; Zeng J; Zhou C; Lai X; Cai W; Xu M
BMC Cancer; 2020 Feb; 20(1):100. PubMed ID: 32024483
[TBL] [Abstract][Full Text] [Related]
22. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.
Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J
Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887
[TBL] [Abstract][Full Text] [Related]
24. A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.
Zhang F; Huang M; Zhou H; Chen K; Jin J; Wu Y; Ying L; Ding X; Su D; Zou D
Ann Surg Oncol; 2019 Nov; 26(12):3912-3919. PubMed ID: 31359285
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of a personalized nomogram of ultrasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemotherapy.
Zhang MQ; Du Y; Zha HL; Liu XP; Cai MJ; Chen ZH; Chen R; Wang J; Wang SJ; Zhang JL; Li CY
Br J Radiol; 2022 Dec; 95(1140):20220626. PubMed ID: 36378247
[TBL] [Abstract][Full Text] [Related]
26.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
27. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer.
Zhang X; Yang Z; Cui W; Zheng C; Li H; Li Y; Lu L; Mao J; Zeng W; Yang X; Zheng J; Shen J
Eur Radiol; 2021 Aug; 31(8):5924-5939. PubMed ID: 33569620
[TBL] [Abstract][Full Text] [Related]
28. Development of MRI-Based Deep Learning Signature for Prediction of Axillary Response After NAC in Breast Cancer.
Zhang B; Yu Y; Mao Y; Wang H; Lv M; Su X; Wang Y; Li Z; Zhang Z; Bian T; Wang Q
Acad Radiol; 2024 Mar; 31(3):800-811. PubMed ID: 37914627
[TBL] [Abstract][Full Text] [Related]
29. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Chen X; Chen X; Yang J; Li Y; Fan W; Yang Z
J Comput Assist Tomogr; 2020; 44(2):275-283. PubMed ID: 32004189
[TBL] [Abstract][Full Text] [Related]
30. [Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by multi-sequence MRI-based radiomic nomogram].
Mao MM; Li HM; Shi J; Qiu QS; Feng F
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):201-208. PubMed ID: 35042289
[No Abstract] [Full Text] [Related]
31. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
[TBL] [Abstract][Full Text] [Related]
32. Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.
Zhang K; Lin J; Lin F; Wang Z; Zhang H; Zhang S; Mao N; Qiao G
J Xray Sci Technol; 2023; 31(4):669-683. PubMed ID: 37066960
[TBL] [Abstract][Full Text] [Related]
33. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
[TBL] [Abstract][Full Text] [Related]
34. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract][Full Text] [Related]
35. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
Sang L; Liu Z; Huang C; Xu J; Wang H
Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
38. Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
Aksu A; Güç ZG; Küçüker KA; Alacacıoğlu A; Turgut B
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500002. PubMed ID: 38527731
[TBL] [Abstract][Full Text] [Related]
39. Computed Tomography-Based Radiomics Analysis for Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Duan Y; Yang G; Miao W; Song B; Wang Y; Yan L; Wu F; Zhang R; Mao Y; Wang Z
J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):199-204. PubMed ID: 36790871
[TBL] [Abstract][Full Text] [Related]
40. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
Kim SY; Cho N; Choi Y; Lee SH; Ha SM; Kim ES; Chang JM; Moon WK
Radiology; 2021 May; 299(2):290-300. PubMed ID: 33754824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
